CD36 and metabolic syndrome: Our studies suggest that CD36 may represent a regulatory target against pathologies caused by excess FAs, and that understanding the mechanisms that mediate and regulate CD36 function will help to understand the mechanisms of FA accumulation and neuropathologies in obese and metabolic syndrome patients.